GMC to create guidance on doctors’ use of social media
April 23, 2012Medical Communications BMA, Facebook, GMC, Twitter, social media
The General Medical Council is creating new draft guidance about what it expects from doctors when they are using social …
Abbott launches online tool for ankylosing spondylitis
April 23, 2012Medical Communications AS, Abbott, NHS, NICE, ankylosing spondylitis
Abbott has launched a new online assessment tool that has the potential to change the landscape of ankylosing spondylitis (AS) …
Pfizer sells nutrition business to Nestlé for $11.9 billion
April 23, 2012Business Services, Sales and Marketing Business, Lipitor, Pfizer, nestle, nutrition
Pfizer has sold its nutrition business to Nestlé for $11.85 billion in cash. Pfizer Nutrition is a leading global pediatric …
AstraZeneca diabetes drug recommended in Europe
April 23, 2012Sales and Marketing AstraZeneca, CHMP, FDA, Merck, WHO, diabetes
AstraZeneca and Bristol-Myers Squibb’s new type II diabetes treatment Forxiga has received a positive opinion by European regulators. The European …
AstraZeneca to buy Ardea for $1.3 billion
April 23, 2012Research and Development, Sales and Marketing Ardea, AstraZeneca, febuxostat, gout
AstraZeneca is to buy Ardea Biosciences for $1 billion to help bolster its pipeline. Under the terms of the agreement, …
Petition launched to raise AF and stroke awareness
April 20, 2012Business Services, Medical Communications, Sales and Marketing AF, Boehringer Ingelheim, Pradaxa, Xarelto, stroke
Various health organisations have called on more people involved in the management of atrial fibrillation (AF) to help raise awareness …
New safety warnings recommended for Gilenya
April 20, 2012Medical Communications, Sales and Marketing EMA, Novartis, gilenya
A safety review of Novartis’ MS treatment Gilenya has concluded the drug should stay on the market, but that patients …
1 in 3 surveyed says social media changes attitudes to medicines
April 20, 2012Business Services, Medical Communications, Sales and Marketing Facebook, Twitter, digital, pwC, social networking
A third of US social media users say it could change the way they think about their medicines, according to …
Hanson Zandi appoints two new directors
April 20, 2012Business Services, Medical Communications, Sales and Marketing Hanson Zandi, health comms
Healthcare comms agency Hanson Zandi has made two new appointments with Damion Hampton and Will Elliott. Hampton joins as account …
Sylva Michelli joins Pegasus as associate director
April 20, 2012Business Services, Medical Communications, Sales and Marketing Pegasus PR, Pegasus PR. Sylva Michelli, Sylva Michelli
Healthcare comms specialist Pegasus has appointed Sylva Michelli as associate director to strengthen the agency’s pharmaceutical and life sciences division. …
Kantar Health appoints Richard Goosey as UK senior director
April 20, 2012Business Services, Medical Communications, Sales and Marketing Kantar Health, Richard Goosey, Roche
Consultancy and marketing insights company Kantar Health has appointed Richard Goosey as UK senior director of Advanced Methods. Goosey has …
EMA request feedback on the draft EU reference dates
April 19, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV
The European Medicines Agency has invited marketing-authorisation holders and other stakeholders to review and provide comments on the draft list …
GSK’s bid for Human Genome Sciences rejected
April 19, 2012Sales and Marketing Benlysta, GSK, Human Genome Sciences, mergers and acquisitions
GlaxoSmithKline has launched a takeover bid for Human Genome Sciences for around $2.5 billion, but has been rejected by the …
Pharma R&D downsizing hits academic researchers
April 19, 2012Research and Development ABPI, academic alliance, academic research
A survey of pharma’s research partnerships and funding of UK academics has raised concerns about the future of British science.The …
Roche abandons Illumina takeover bid
April 19, 2012Sales and Marketing Diagnostics, Illumina, Roche, mergers and acquisitions
Roche has conceded defeat in its bid to buy Illumina, after shareholders of the diagnostics firm blocked the takeover – …
Kantar Health Names Goosey Senior Director, Advanced Methods in UK
April 18, 2012Business Services Kantar Health, Richard Goosey, clinical statistics, market research
NEW YORK, April 18, 2012—Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, has named Richard Goosey Senior …
NICE rejects Avastin for breast cancer
April 18, 2012Sales and Marketing EMA, NICE, Roche, avastin, breast cancer
In a blow for Roche, NICE has turned down its cancer drug Avastin because of ‘too many uncertainties’ over cost …
Pharmaceutical marketers – put your head in the clouds
April 17, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Blyth, Cloud Computing, MSI, digital, iPod, ipad
The moment has arrived for the pharma industry to embrace online planning tools.The convergence of reliable and secure cloud-based computing, …
China bans medicines formulated in toxic capsules
April 17, 2012Manufacturing and Production China, SFDA, impurities, manufacturing
China’s State Food and Drug Administration (SFDA) has banned the sale of 13 medicines thought to be manufactured using contaminated …
Merck does cancer drug deal with Endocyte
April 17, 2012Research and Development, Sales and Marketing Cancer, Endocyte, Merck, NSCLC, vintafolide
Merck is to pay $120 million to US biopharma company Endocyte as part of a deal to develop and commercialise …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
